Biotech RadarJobs updated

COMPANY

Incendia Therapeutics

HQ: Cambridge, MA source · incendiatx.com ↗

Clinical Phase 1

Keywords: antibody monoclonal antibody oncology cancer tumors Non Small Cell Lung Cancer NSCLC PRTH-101

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT05753722A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced MalignanciesPhase 1CompletedMar 3, 2023Sep 2, 2026 (actual)
Feedback